My only concern is where does this acquisition fit? Are we a cbd company? Are we a dermo company? Where does micro fit? We need to make sure we retain our focus.
Ann: Dermatology Asset Acquired to Accelerate Path to Revenue, page-17
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
33.5¢ |
Change
-0.005(1.47%) |
Mkt cap ! $615.4M | |||
| Open | High | Low | Value | Volume |
| 33.5¢ | 34.0¢ | 33.0¢ | $375.6K | 1.109M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 150828 | 33.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 34.0¢ | 178535 | 6 |
View Market Depth
| Last trade - 10.32am 10/07/2024 (20 minute delay) ? |
| BOT (ASX) Chart |